148 related articles for article (PubMed ID: 11877365)
61. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
Szabo B; Fritz T; Wedzony K
Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647
[TBL] [Abstract][Full Text] [Related]
62. An unexpected central hypertensive effect of the new imidazoline compound benazoline.
Bruban V; Feldman J; Dontenwill M; Greney H; Brasili L; Giannella M; Pigini M; Bousquet P
Ann N Y Acad Sci; 1999 Jun; 881():102-5. PubMed ID: 10415903
[No Abstract] [Full Text] [Related]
63. Central hypotensive effects of the alpha2a-adrenergic receptor subtype.
MacMillan LB; Hein L; Smith MS; Piascik MT; Limbird LE
Science; 1996 Aug; 273(5276):801-3. PubMed ID: 8670421
[TBL] [Abstract][Full Text] [Related]
64. Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine.
Head GA; Burke S
J Cardiovasc Pharmacol; 1991 Dec; 18(6):819-26. PubMed ID: 1725893
[TBL] [Abstract][Full Text] [Related]
65. Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice.
Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 1999 Jul; 290(1):403-12. PubMed ID: 10381806
[TBL] [Abstract][Full Text] [Related]
66. [Selectivity of a new antihypertensive agent, rilmenidine, for imidazoline receptors in the human brain].
Bricca G; Dontenwill M; Feldman J; Belcourt A; Bousquet P
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1325-8. PubMed ID: 1979731
[TBL] [Abstract][Full Text] [Related]
67. Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors.
Harron DW
Am J Hypertens; 1992 Apr; 5(4 Pt 2):91S-98S. PubMed ID: 1350732
[TBL] [Abstract][Full Text] [Related]
68. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
Gilsbach R; Schneider J; Lother A; Schickinger S; Leemhuis J; Hein L
Cardiovasc Res; 2010 Jun; 86(3):432-42. PubMed ID: 20083574
[TBL] [Abstract][Full Text] [Related]
69. Alpha 2A-adrenergic receptor signaling underlies synergistic enhancement of ethanol-induced behavioral impairment by clonidine.
Bender TS; Abdel-Rahman AA
Alcohol Clin Exp Res; 2009 Mar; 33(3):408-18. PubMed ID: 19120051
[TBL] [Abstract][Full Text] [Related]
70. Cardiovascular regulation by central adrenergic mechanisms and its alteration by hypotensive drugs.
Haeusler G
Circ Res; 1975 Jun; 36(6 Suppl 1):223-32. PubMed ID: 1093754
[TBL] [Abstract][Full Text] [Related]
71. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors.
Ogidigben MJ; Chu TC; Potter DE
Exp Eye Res; 2001 Mar; 72(3):331-9. PubMed ID: 11180982
[TBL] [Abstract][Full Text] [Related]
72. The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
Koletsky RJ; Velliquette RA; Ernsberger P
Ann N Y Acad Sci; 2003 Dec; 1009():251-61. PubMed ID: 15028595
[TBL] [Abstract][Full Text] [Related]
73. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
[TBL] [Abstract][Full Text] [Related]
74. Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats.
Sannajust F; Cerutti C; Koenig-Bérard E; Sassard J
Br J Pharmacol; 1992 Mar; 105(3):542-8. PubMed ID: 1352719
[TBL] [Abstract][Full Text] [Related]
75. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines.
Bousquet P; Feldman J; Schwartz J
J Pharmacol Exp Ther; 1984 Jul; 230(1):232-6. PubMed ID: 6146707
[TBL] [Abstract][Full Text] [Related]
76. [Interaction of rilmenidine with renal imidazoline-guanidine sites].
Lachaud V; Bidet M; Coupry I; Podevin RA; Poujeol P; Parini A
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():15-8. PubMed ID: 2576516
[TBL] [Abstract][Full Text] [Related]
77. Inhibition of centrally induced ventricular arrhythmias by rilmenidine and idazoxan in rabbits.
Roegel JC; Yannoulis N; De Jong W; Monassier L; Feldman J; Bousquet P
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):598-605. PubMed ID: 8938658
[TBL] [Abstract][Full Text] [Related]
78. Sympathoinhibitory effects of rilmenidine may be mediated by sites located below the brainstem.
Sannajust F; Barrès C; Koenig-Bérard E; Sassard J
Br J Pharmacol; 1992 Mar; 105(3):535-41. PubMed ID: 1352718
[TBL] [Abstract][Full Text] [Related]
79. Central actions of agmatine in conscious spontaneously hypertensive rats.
Briaud S; Zhang BL; Sannajust F
Clin Exp Hypertens; 2005 Nov; 27(8):619-27. PubMed ID: 16303638
[TBL] [Abstract][Full Text] [Related]
80. Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs.
Mammoto T; Kamibayashi T; Hayashi Y; Yamatodani A; Takada K; Yoshiya I
Br J Pharmacol; 1996 Apr; 117(8):1744-8. PubMed ID: 8732285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
